Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature.

ABSTRACT:

Rationale

Miller Fisher syndrome (MFS) is a rare variant of Guillain-Barre syndrome, classically diagnosed based on the clinical triad of ataxia, areflexia, and ophthalmoplegia. MFS is usually preceded by viral infections and febrile illness; however, only a few cases have been reported after vaccinations.

Patient concerns

A 53-year-old hypertensive male presented with a 2-day history of progressive ascending paralysis of the lower limbs along with diplopia and ataxia, 8 days after the first dose of the Sinovac-Coronavac coronavirus disease 2019 (COVID-19) vaccination, with no prior history of any predisposing infections or triggers.

Diagnoses

Physical examination showed moderate motor and sensory loss with areflexia in the lower limbs bilaterally. Routine blood inves

SUBMITTER: Siddiqi AR 

PROVIDER: S-EPMC9276158 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature